{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:59:47Z","timestamp":1790891987698,"version":"4.1.0"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pet.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cpet.2026.08.001","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:36:10Z","timestamp":1790890570000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fluorodeoxyglucose-PET in Myocardial Viability and Ischemic Heart Disease"],"prefix":"10.1016","author":[{"given":"Amal","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.cpet.2026.08.001_bib1","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1093\/eurheartj\/ehm355","article-title":"Joint ESC\/ACCF\/AHA\/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction","volume":"28","author":"Thygesen","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpet.2026.08.001_bib2","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.15.04291","article-title":"Global, regional, and national burden of ischaemic heart disease from 1990 to 2021: a comprehensive analysis based on the global burden of disease study 2021","volume":"15","author":"Liu","year":"2025","journal-title":"J Glob Health"},{"issue":"14","key":"10.1016\/j.cpet.2026.08.001_bib3","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCULATIONAHA.113.004042","article-title":"Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the global burden of disease 2010 study","volume":"129","author":"Moran","year":"2014","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cpet.2026.08.001_bib4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ejhf.1747","article-title":"Ischaemic cardiomyopathy. Pathophysiological insights, diagnostic management and the roles of revascularisation and device treatment. Gaps and dilemmas in the era of advanced technology","volume":"22","author":"Cabac-Pogorevici","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10.1016\/j.cpet.2026.08.001_bib5","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41569-021-00506-7","article-title":"Myocardial stunning and hibernation revisited","volume":"18","author":"Heusch","year":"2021","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"10.1016\/j.cpet.2026.08.001_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10741-017-9594-7","article-title":"SPECT and PET in ischemic heart failure","volume":"22","author":"Angelidis","year":"2017","journal-title":"Heart Fail Rev"},{"issue":"3 Suppl","key":"10.1016\/j.cpet.2026.08.001_bib7","first-page":"I122","article-title":"Positron emission tomography for the assessment of myocardial viability","volume":"84","author":"Schelbert","year":"1991","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cpet.2026.08.001_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015502","article-title":"Stunned and hibernating myocardium: where are we nearly 4 decades later?","volume":"9","author":"Kloner","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpet.2026.08.001_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pcad.2024.12.008","article-title":"The complex role of cardiovascular imaging in viability testing","volume":"88","author":"Nealy","year":"2025","journal-title":"Prog Cardiovasc Dis"},{"issue":"4","key":"10.1016\/j.cpet.2026.08.001_bib10","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/j.2040-4603.2015.tb00658.x","article-title":"Physiological implications of myocardial scar structure","volume":"5","author":"Richardson","year":"2015","journal-title":"Compr Physiol"},{"issue":"16","key":"10.1016\/j.cpet.2026.08.001_bib11","first-page":"1","article-title":"Positron emission tomography for the assessment of myocardial viability","volume":"5","year":"2005","journal-title":"Ont Health Technol Assess Ser"},{"issue":"7","key":"10.1016\/j.cpet.2026.08.001_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/HCI.0000000000000053","article-title":"State of the art: imaging for myocardial viability: a scientific statement from the American heart association","volume":"13","author":"Garcia","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.cpet.2026.08.001_bib13","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1161\/01.CIR.91.6.1619","article-title":"Evaluation of myocardial cell damage by In-111-monoclonal antimyosin antibodies in patients under chronic tricyclic antidepressant drug treatment","volume":"91","author":"Mart\u00ed","year":"1995","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.cpet.2026.08.001_bib14","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/CIRCRESAHA.116.307898","article-title":"Myocardial viability: survival mechanisms and molecular imaging targets in acute and chronic ischemia","volume":"120","author":"Gewirtz","year":"2017","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.cpet.2026.08.001_bib15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/CIRCULATIONAHA.105.541664","article-title":"Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction","volume":"113","author":"Tarakji","year":"2006","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cpet.2026.08.001_bib16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1023\/B:CAIM.0000004302.68305.80","article-title":"Biphasic response to dobutamine predicts improvement of left ventricular dysfunction after revascularization: correlation with positron emission and rest-redistribution 201Tl tomographies","volume":"19","author":"Hernandez-Pampaloni","year":"2003","journal-title":"Int J Cardiovasc Imaging"},{"issue":"25","key":"10.1016\/j.cpet.2026.08.001_bib17","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1161\/CIRCULATIONAHA.104.489310","article-title":"Incremental value of strain rate analysis as an adjunct to wall-motion scoring for assessment of myocardial viability by dobutamine echocardiography: a follow-up study after revascularization","volume":"112","author":"Hanekom","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cpet.2026.08.001_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.124.016517","article-title":"Echocardiography: past, present, and future","volume":"17","author":"Gillam","year":"2024","journal-title":"Circ Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.cpet.2026.08.001_bib19","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/RLI.0b013e318181c8dd","article-title":"Multidetector computed tomography in reperfused acute myocardial infarction. Assessment of infarct size and no-reflow in comparison with cardiac magnetic resonance imaging","volume":"43","author":"Jacquier","year":"2008","journal-title":"Investig Radiol"},{"issue":"22","key":"10.1016\/j.cpet.2026.08.001_bib20","doi-asserted-by":"crossref","first-page":"7062","DOI":"10.3390\/jcm12227062","article-title":"Dynamic CT myocardial perfusion: the role of functional evaluation in the diagnosis of coronary artery disease","volume":"12","author":"Zdanowicz","year":"2023","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.cpet.2026.08.001_bib21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcct.2019.09.003","article-title":"Dynamic CT myocardial perfusion imaging","volume":"14","author":"Nieman","year":"2020","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"8","key":"10.1016\/j.cpet.2026.08.001_bib22","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJMoa1807365","article-title":"Myocardial viability and long-term outcomes in ischemic cardiomyopathy","volume":"381","author":"Panza","year":"2019","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.cpet.2026.08.001_bib23","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1161\/01.CIR.94.11.2712","article-title":"Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201Tl tomography versus dobutamine echocardiography","volume":"94","author":"Perrone-Filardi","year":"1996","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cpet.2026.08.001_bib24","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/0735-1097(94)90110-4","article-title":"Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: feasibility and reliability for prediction of postrevascularization outcome of asynergic territories","volume":"24","author":"Bisi","year":"1994","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.cpet.2026.08.001_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/CIRCULATIONAHA.107.702993","article-title":"Stunning, hibernation, and assessment of myocardial viability","volume":"117","author":"Camici","year":"2008","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.cpet.2026.08.001_bib26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cpcardiol.2007.04.001","article-title":"Hibernating myocardium: diagnosis and patient outcomes","volume":"32","author":"Schinkel","year":"2007","journal-title":"Curr Probl Cardiol"},{"issue":"2","key":"10.1016\/j.cpet.2026.08.001_bib27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1067\/mcd.2001.109973","article-title":"Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium","volume":"26","author":"Bax","year":"2001","journal-title":"Curr Probl Cardiol"},{"issue":"9","key":"10.1016\/j.cpet.2026.08.001_bib28","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jacc.2011.09.073","article-title":"Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction: impact of revascularization therapy","volume":"59","author":"Gerber","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.cpet.2026.08.001_bib29","first-page":"74","article-title":"Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance: assessment of patients with suspected coronary artery disease","volume":"47","author":"Berman","year":"2006","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2026.08.001_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1532-429X-10-18","article-title":"Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art","volume":"10","author":"Gerber","year":"2008","journal-title":"J Cardiovasc Magn Reson"},{"issue":"20","key":"10.1016\/j.cpet.2026.08.001_bib31","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJM200011163432003","article-title":"The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction","volume":"343","author":"Kim","year":"2000","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.cpet.2026.08.001_bib32","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/hc3501.096798","article-title":"Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function","volume":"104","author":"Choi","year":"2001","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cpet.2026.08.001_bib33","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00330-005-2653-9","article-title":"Myocardial viability assessment in patients with highly impaired left ventricular function: comparison of delayed enhancement, dobutamine stress MRI, end-diastolic wall thickness, and TI201-SPECT with functional recovery after revascularization","volume":"15","author":"Gutberlet","year":"2005","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.cpet.2026.08.001_bib34","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jcmg.2012.02.009","article-title":"CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysis of prospective trials","volume":"5","author":"Romero","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cpet.2026.08.001_bib35","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41598-024-85029-0","article-title":"Machine learning-based interpretation of non-contrast feature tracking strain analysis and T1\/T2 mapping for assessing myocardial viability","volume":"15","author":"GhaffariJolfayi","year":"2025","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.cpet.2026.08.001_bib36","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3390\/medicina58030368","article-title":"Comparative analysis of myocardial viability multimodality imaging in patients with previous myocardial infarction and symptomatic heart failure","volume":"58","author":"Kazakauskaite","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"12","key":"10.1016\/j.cpet.2026.08.001_bib37","article-title":"Comparison of myocardial viability by cardiac magnetic resonance imaging and echocardiography in patients with myocardial infarction: an observational cross-sectional study","volume":"17","author":"Bhatta","year":"2025","journal-title":"Cureus"},{"issue":"Suppl 1","key":"10.1016\/j.cpet.2026.08.001_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10554-009-9571-x","article-title":"Quantification in cardiac MRI: advances in image acquisition and processing","volume":"26 Suppl 1","author":"Attili","year":"2010","journal-title":"Int J Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.cpet.2026.08.001_bib39","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12350-010-9209-3","article-title":"Viability assessment with MRI is superior to FDG-PET for viability: con","volume":"17","author":"Patterson","year":"2010","journal-title":"J Nucl Cardiol"},{"issue":"15","key":"10.1016\/j.cpet.2026.08.001_bib40","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.3390\/jcm14155529","article-title":"The role of imaging modalities in estimating myocardial viability: a narrative review","volume":"14","author":"Modak","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.cpet.2026.08.001_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2025.102619","article-title":"Clinical indications for positron emission tomography myocardial perfusion imaging and myocardial blood flow quantification: an American Society of Nuclear Cardiology position statement","volume":"57","author":"Bateman","year":"2026","journal-title":"J Nucl Cardiol"},{"issue":"5","key":"10.1016\/j.cpet.2026.08.001_bib42","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s12350-016-0626-9","article-title":"American Society of Nuclear Cardiology and Society of Nuclear Medicine and molecular imaging joint position statement on the clinical indications for myocardial perfusion PET","volume":"23","author":"Bateman","year":"2016","journal-title":"J Nucl Cardiol"},{"issue":"9","key":"10.1016\/j.cpet.2026.08.001_bib43","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/jcdd12090338","article-title":"Hybrid PET\/CT and PET\/MR in coronary artery disease: an update for Clinicians, with insights into AI-Guided integration","volume":"12","author":"Veneziano","year":"2025","journal-title":"J Cardiovasc Dev Dis"},{"issue":"5","key":"10.1016\/j.cpet.2026.08.001_bib44","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1053\/j.semnuclmed.2024.05.007","article-title":"Cardiac PET\/MRI: recent developments and future aspects","volume":"54","author":"Kazimierczyk","year":"2024","journal-title":"Semin Nucl Med"},{"issue":"5","key":"10.1016\/j.cpet.2026.08.001_bib45","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1148\/rg.315115056","article-title":"Cardiac PET\/CT for the evaluation of known or suspected coronary artery disease","volume":"31","author":"Di Carli","year":"2011","journal-title":"Radiographics"},{"issue":"10 Pt A","key":"10.1016\/j.cpet.2026.08.001_bib46","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jcmg.2017.07.008","article-title":"MR\/PET imaging of the cardiovascular system","volume":"10","author":"Robson","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.cpet.2026.08.001_bib47","first-page":"355","article-title":"Myocardial viability testing to guide coronary revascularization","volume":"7","author":"L\u00f6ffler","year":"2018","journal-title":"Interv Cardiol Clin"},{"issue":"3","key":"10.1016\/j.cpet.2026.08.001_bib48","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0735-1097(92)90008-B","article-title":"Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography","volume":"20","author":"Eitzman","year":"1992","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.cpet.2026.08.001_bib49","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.jacc.2007.09.006","article-title":"F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2)","volume":"50","author":"Beanlands","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpet.2026.08.001_bib50","doi-asserted-by":"crossref","DOI":"10.1007\/s11883-023-01107-0","article-title":"The role of cardiac PET in diagnosis and prognosis of ischemic heart disease: optimal modality across different patient populations","author":"Nayfeh","year":"2023","journal-title":"Curr Atheroscler Rep"},{"issue":"3","key":"10.1016\/j.cpet.2026.08.001_bib51","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0033-0620(72)90029-1","article-title":"Myocardial utilization of carbohydrate and lipids","volume":"15","author":"Neely","year":"1972","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cpet.2026.08.001_bib52","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.ph.36.030174.002213","article-title":"Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle","volume":"36","author":"Neely","year":"1974","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"10.1016\/j.cpet.2026.08.001_bib53","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jcmg.2011.11.009","article-title":"Targeted metabolic imaging to improve the management of heart disease","volume":"5","author":"Osterholt","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.cpet.2026.08.001_bib54","first-page":"235","article-title":"Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution","volume":"27","author":"Hamacher","year":"1986","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.cpet.2026.08.001_bib55","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s12350-016-0522-3","article-title":"ASNC imaging guidelines\/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures","volume":"23","author":"Dilsizian","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.cpet.2026.08.001_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2025.102480","article-title":"How to prepare patients for fluorine-18 fluorodeoxyglucose positron emission tomography myocardial viability assessment","volume":"57","author":"Lima","year":"2026","journal-title":"J Nucl Cardiol"},{"issue":"7","key":"10.1016\/j.cpet.2026.08.001_bib57","first-page":"1255","article-title":"Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography","volume":"33","author":"Knuuti","year":"1992","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.cpet.2026.08.001_bib58","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s002590050154","article-title":"A simplified intravenous glucose loading protocol for fluorine-18 fluorodeoxyglucose cardiac single-photon emission tomography","volume":"24","author":"Martin","year":"1997","journal-title":"Eur J Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2026.08.001_bib59","doi-asserted-by":"crossref","first-page":"602","DOI":"10.2967\/jnumed.121.262432","article-title":"18F-FDG PET in myocardial viability assessment: a practical and time-efficient protocol","volume":"63","author":"Mhlanga","year":"2022","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.cpet.2026.08.001_bib60","first-page":"877","article-title":"Effect of diabetes mellitus on myocardial 18F-FDG SPECT using acipimox for the assessment of myocardial viability","volume":"44","author":"Schinkel","year":"2003","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.cpet.2026.08.001_bib61","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s10554-011-9983-2","article-title":"Acipimox-enhanced 18F-fluorodeoxyglucose positron emission tomography for characterizing and predicting early remodeling in the rat infarct model","volume":"28","author":"Bousquenaud","year":"2012","journal-title":"Int J Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.cpet.2026.08.001_bib62","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1067\/mnc.2002.125391","article-title":"Safety and feasibility of cardiac FDG SPECT following oral administration of acipimox, a nicotinic acid derivative: comparison of image quality with hyperinsulinemic euglycemic clamping in nondiabetic patients","volume":"9","author":"Bax","year":"2002","journal-title":"J Nucl Cardiol"},{"issue":"4","key":"10.1016\/j.cpet.2026.08.001_bib63","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.cpet.2026.08.001_bib64","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.2967\/jnumed.121.261989","article-title":"Practical guide for interpreting and reporting cardiac PET measurements of myocardial blood flow: an information statement from the American Society of Nuclear Cardiology, and the Society of Nuclear medicine and molecular imaging","volume":"62","author":"Bateman","year":"2021","journal-title":"J Nucl Med"},{"issue":"9","key":"10.1016\/j.cpet.2026.08.001_bib65","first-page":"1492","article-title":"A reverse flow-metabolism mismatch pattern on PET is related to multivessel disease in patients with acute myocardial infarction","volume":"40","author":"Yamagishi","year":"1999","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.cpet.2026.08.001_bib66","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1097\/RLU.0000000000001312","article-title":"Reverse mismatch pattern in cardiac 18F-FDG viability PET\/CT is not associated with poor outcome of revascularization: a retrospective outcome study of 91 patients with heart failure","volume":"41","author":"Hansen","year":"2016","journal-title":"Clin Nucl Med"},{"issue":"7","key":"10.1016\/j.cpet.2026.08.001_bib67","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0735-1097(02)01726-6","article-title":"Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis","volume":"39","author":"Allman","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.cpet.2026.08.001_bib68","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0002-8703(03)00428-9","article-title":"Revascularization in patients with coronary artery disease, left ventricular dysfunction, and viability: a meta-analysis","volume":"146","author":"Bourque","year":"2003","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.cpet.2026.08.001_bib69","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s12350-010-9226-2","article-title":"Quantity of viable myocardium required to improve survival with revascularization in patients with ischemic cardiomyopathy: a meta-analysis","volume":"17","author":"Inaba","year":"2010","journal-title":"J Nucl Cardiol"},{"issue":"9","key":"10.1016\/j.cpet.2026.08.001_bib70","article-title":"Long-term Follow-Up of outcomes with F-18-Fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction secondary to coronary disease","volume":"9","author":"Mc","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"issue":"9","key":"10.1016\/j.cpet.2026.08.001_bib71","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jcmg.2009.02.017","article-title":"Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial","volume":"2","author":"D\u2019Egidio","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.cpet.2026.08.001_bib72","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2967\/jnumed.109.065938","article-title":"18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial","volume":"51","author":"Abraham","year":"2010","journal-title":"J Nucl Med"},{"issue":"16","key":"10.1016\/j.cpet.2026.08.001_bib73","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","article-title":"Coronary-artery bypass surgery in patients with ischemic cardiomyopathy","volume":"374","author":"Velazquez","year":"2016","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.cpet.2026.08.001_bib74","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.cpet.2026.08.001_bib75","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa1100358","article-title":"Myocardial viability and survival in ischemic left ventricular dysfunction","volume":"364","author":"Bonow","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpet.2026.08.001_bib76","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/1745-6215-14-218","article-title":"Alternative Imaging Modalities in ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial","volume":"14","author":"O\u2019Meara","year":"2013","journal-title":"Trials"},{"issue":"12","key":"10.1016\/j.cpet.2026.08.001_bib77","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jamacardio.2023.3803","article-title":"Viability and outcomes with revascularization or medical therapy in ischemic ventricular dysfunction","volume":"8","author":"Perera","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.cpet.2026.08.001_bib78","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.mri.2003.07.006","article-title":"F-18-FDG uptake is a reliable predictory of functional recovery of akinetic but viable infarct regions as defined by magnetic resonance imaging before and after revascularization","volume":"22","author":"Schmidt","year":"2004","journal-title":"Magn Reson Imaging"},{"issue":"7","key":"10.1016\/j.cpet.2026.08.001_bib79","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/eurheartj\/ehi747","article-title":"Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol","volume":"27","author":"K\u00fchl","year":"2006","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.cpet.2026.08.001_bib80","first-page":"661","article-title":"PET\/MRI early after myocardial infarction: evaluation of viability with late gadolinium enhancement transmurality vs. 18F-FDG uptake","volume":"16","author":"Rischpler","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.cpet.2026.08.001_bib81","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.cpet.2026.08.001_bib82","first-page":"e18","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American college of Cardiology\/American Heart Association Joint Committee on clinical practice Guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cpet.2026.08.001_bib83","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/jmri.28554","article-title":"PET-MRI of coronary artery disease","volume":"57","author":"Whittington","year":"2023","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"10.1016\/j.cpet.2026.08.001_bib84","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1148\/radiol.13130231","article-title":"Hybrid PET\/MR imaging of the heart: feasibility and initial results","volume":"268","author":"Nensa","year":"2013","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.cpet.2026.08.001_bib85","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.004316","article-title":"Prospective evaluation of 18f-fdg uptake in post-ischemic myocardium by simultaneous pet\/mri as a prognostic marker of functional outcome","volume":"9","author":"Rischpler","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"issue":"13","key":"10.1016\/j.cpet.2026.08.001_bib86","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1007\/s00259-020-04877-w","article-title":"Hybrid PET\/MR imaging for the prediction of left ventricular recovery after percutaneous revascularisation of coronary chronic total occlusions","volume":"47","author":"Vitadello","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.cpet.2026.08.001_bib87","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/MNM.0000000000000680","article-title":"Downstream indication to revascularization following hybrid cardiac PET\/MRI: preliminary results","volume":"38","author":"Priamo","year":"2017","journal-title":"Nucl Med Commun"},{"issue":"6","key":"10.1016\/j.cpet.2026.08.001_bib88","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s12350-017-0918-8","article-title":"Hybrid PET\/CT and PET\/MRI imaging of vulnerable coronary plaque and myocardial scar tissue in acute myocardial infarction","volume":"25","author":"Marchesseau","year":"2018","journal-title":"J Nucl Cardiol"},{"issue":"4","key":"10.1016\/j.cpet.2026.08.001_bib89","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.cpet.2020.06.007","article-title":"Applications of pet-mri in cardiovascular disorders","volume":"15","author":"Cardoso","year":"2020","journal-title":"Pet Clin"},{"issue":"4","key":"10.1016\/j.cpet.2026.08.001_bib90","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/CIRCIMAGING.110.961854","article-title":"Targeted imaging of the spatial and temporal variation of matrix metalloproteinase activity in a porcine model of postinfarct remodeling: relationship to myocardial dysfunction","volume":"4","author":"Sahul","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"issue":"12","key":"10.1016\/j.cpet.2026.08.001_bib91","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jcmg.2015.09.008","article-title":"Molecular imaging of the chemokine receptor CXCR4 after acute myocardial infarction","volume":"8","author":"Thackeray","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.cpet.2026.08.001_bib92","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jcmg.2011.05.003","article-title":"The future of molecular imaging","volume":"4","author":"Sinusas","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.cpet.2026.08.001_bib93","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cpet.2021.06.011","article-title":"Artificial intelligence and cardiac PET\/computed tomography imaging","volume":"17","author":"Miller","year":"2022","journal-title":"Pet Clin"},{"key":"10.1016\/j.cpet.2026.08.001_bib94","doi-asserted-by":"crossref","DOI":"10.4414\/SMW.2022.w30123","article-title":"PET-based artificial intelligence applications in cardiac nuclear medicine","volume":"152","author":"Popescu","year":"2022","journal-title":"Swiss Med Wkly"},{"issue":"5","key":"10.1016\/j.cpet.2026.08.001_bib95","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00259-021-05341-z","article-title":"Position paper of the EACVI and EANM on artificial intelligence applications in multimodality cardiovascular imaging using SPECT\/CT, PET\/CT, and cardiac CT","volume":"48","author":"Slart","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1016\/j.cpet.2026.08.001_bib96","article-title":"A novel approach to identifying hibernating myocardium using radiomics-based machine learning","volume":"16","author":"Khangembam","year":"2024","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.cpet.2026.08.001_bib97","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/abe225","article-title":"Low-dose PET image noise reduction using deep learning: application to cardiac viability FDG imaging in patients with ischemic heart disease","volume":"66","author":"Ladefoged","year":"2021","journal-title":"Phys Med Biol"},{"issue":"1 Pt 1","key":"10.1016\/j.cpet.2026.08.001_bib98","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jcmg.2019.08.009","article-title":"Deep learning in quantitative PET myocardial perfusion imaging: a study on cardiovascular event prediction","volume":"13","author":"Juarez-Orozco","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.cpet.2026.08.001_bib99","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1007\/s12350-020-02160-x","article-title":"Evaluation of the diagnostic value of joint PET myocardial perfusion and metabolic imaging for vascular stenosis in patients with obstructive coronary artery disease","volume":"28","author":"Wang","year":"2021","journal-title":"J Nucl Cardiol"},{"issue":"6","key":"10.1016\/j.cpet.2026.08.001_bib100","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1109\/TRPMS.2020.3031274","article-title":"Multiparametric cardiac 18F-FDG PET in humans: kinetic model selection and identifiability analysis","volume":"4","author":"Zuo","year":"2020","journal-title":"IEEE Trans Radiat Plasma Med Sci"},{"issue":"1","key":"10.1016\/j.cpet.2026.08.001_bib101","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12350-018-1395-4","article-title":"Clinical significance of quantitative assessment of glucose utilization in patients with ischemic cardiomyopathy","volume":"27","author":"Ko","year":"2020","journal-title":"J Nucl Cardiol"},{"issue":"4","key":"10.1016\/j.cpet.2026.08.001_bib102","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s41666-024-00172-7","article-title":"A methodology to measure glucose metabolism by quantitative analysis of PET images","volume":"8","author":"Vizza","year":"2024","journal-title":"J Healthc Inform Res"},{"issue":"15","key":"10.1016\/j.cpet.2026.08.001_bib103","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ac15a6","article-title":"Multiparametric cardiac 18F-FDG PET in humans: pilot comparison of FDG delivery rate with 82Rb myocardial blood flow","volume":"66","author":"Zuo","year":"2021","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.cpet.2026.08.001_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2026.102652","article-title":"New opportunities for nuclear cardiology with total-body positron emission tomography\/computed tomography","author":"Saraste","year":"2026","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.cpet.2026.08.001_bib105","doi-asserted-by":"crossref","DOI":"10.1007\/s11307-025-02074-5","article-title":"An optimized fast track protocol to enhance the image quality of 18F-FDG PET myocardial viability imaging in diabetic CAD patients: a randomized controlled trial","author":"Mandal","year":"2026","journal-title":"Mol Imaging Biol"},{"issue":"5","key":"10.1016\/j.cpet.2026.08.001_bib106","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1007\/s12350-021-02749-w","article-title":"Feasibility and application of trimetazidine in 18F-FDG PET myocardial metabolic imaging of diabetic mellitus patients with severe coronary artery disease: a prospective, self-controlled study","volume":"29","author":"Shao","year":"2022","journal-title":"J Nucl Cardiol"},{"issue":"5","key":"10.1016\/j.cpet.2026.08.001_bib107","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3390\/pharmaceutics15051532","article-title":"Tracers for cardiac imaging: targeting the future of viable myocardium","volume":"15","author":"Nappi","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.cpet.2026.08.001_bib108","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s40119-022-00295-1","article-title":"Emerging PET tracers in cardiac molecular imaging","volume":"12","author":"Singh","year":"2023","journal-title":"Cardiol Ther"},{"issue":"6","key":"10.1016\/j.cpet.2026.08.001_bib109","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.nuclcard.2007.07.009","article-title":"Mechanism of uptake and retention of F-18 BMS-747158-02 in cardiomyocytes: a novel PET myocardial imaging agent","volume":"14","author":"Yalamanchili","year":"2007","journal-title":"J Nucl Cardiol"},{"issue":"7","key":"10.1016\/j.cpet.2026.08.001_bib110","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.tcm.2025.03.008","article-title":"18F labeled myocardial perfusion PET: new precision in cardiac imaging","volume":"35","author":"Higuchi","year":"2025","journal-title":"Trends Cardiovasc Med"},{"issue":"11","key":"10.1016\/j.cpet.2026.08.001_bib111","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1097\/MS9.0000000000004032","article-title":"Flurpiridaz F18: a new era in nuclear cardiac imaging \u2013 the first FDA-approved radiotracer in 30 years","volume":"87","author":"Ayalew","year":"2025","journal-title":"Ann Med Surg (Lond)"},{"issue":"6","key":"10.1016\/j.cpet.2026.08.001_bib112","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2967\/jnumed.110.085993","article-title":"Stable delineation of the ischemic area by the PET perfusion tracer 18F-fluorobenzyl triphenyl phosphonium after transient coronary occlusion","volume":"52","author":"Higuchi","year":"2011","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.cpet.2026.08.001_bib113","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1007\/s12350-021-02866-6","article-title":"Can the promise of radionuclide cardiac innervation imaging be fulfilled?","volume":"29","author":"Travin","year":"2022","journal-title":"J Nucl Cardiol"},{"issue":"6","key":"10.1016\/j.cpet.2026.08.001_bib114","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1161\/CIRCRESAHA.118.314030","article-title":"Molecular imaging visualizes recruitment of inflammatory monocytes and macrophages to the injured heart","volume":"124","author":"Heo","year":"2019","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.cpet.2026.08.001_bib115","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.2967\/jnumed.119.226993","article-title":"Molecular imaging of fibroblast activity after myocardial infarction using a 68Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04","volume":"60","author":"Varasteh","year":"2019","journal-title":"J Nucl Med"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859826001045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859826001045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:36:23Z","timestamp":1790890583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859826001045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":115,"alternative-id":["S1556859826001045"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2026.08.001","relation":{},"ISSN":["1556-8598"],"issn-type":[{"value":"1556-8598","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluorodeoxyglucose-PET in Myocardial Viability and Ischemic Heart Disease","name":"articletitle","label":"Article Title"},{"value":"PET Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpet.2026.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}